GEHCGE HealthCare Technologies Inc.
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
- Revenue
- $20.6B
- 4.8% YoY
- Operating margin
- 13.4%
- 0.4% YoY
- EBITDA
- $3.0B
- 5.4% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 2.3×
- $7.1B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear95% of net incomeCash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowClear13% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear39% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $17.6B | $18.3B | $19.6B | $19.7B | $20.6B | 4.8% |
| Operating income | $2.8B | $2.5B | $2.4B | $2.6B | $2.8B | 5.3% |
| Net income | $2.2B | $1.9B | $1.6B | $2.0B | $2.1B | 4.6% |
| Operating cash flow | $1.6B | $2.1B | $2.1B | $2.0B | $2.0B | 1.6% |
| Capex | $248M | $310M | $387M | $401M | $482M | 20% |
| Stock-based comp | $76M | $67M | $114M | $125M | $130M | 4.0% |
| Buybacks | — | — | $0 | $0 | $200M | |
| Dividends | $0 | $0 | $41M | $55M | $64M | 16% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
No pay-versus-performance disclosure yet.